wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q54970340-1898208B-073F-455C-8E39-CC18C56FAA45
Q54970340-1898208B-073F-455C-8E39-CC18C56FAA45
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54970340-1898208B-073F-455C-8E39-CC18C56FAA45
Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells.
P2860
Q54970340-1898208B-073F-455C-8E39-CC18C56FAA45
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54970340-1898208B-073F-455C-8E39-CC18C56FAA45
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4554898df7b6dcb9f0174275467905061e68a83d
P2860
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.